Endpoints News 2025-12-15 FDA wants to use more real-world data and calls again for early-phase trials reform
Endpoints News 2025-12-15 Enhertu combo wins FDA approval for first-line use in metastatic breast cancer
Endpoints News 2025-12-15 FDA speeds up review of J&J's multiple myeloma combo treatment following positive data
Endpoints News 2025-12-15 With GLP-1 microdoses, Noom targets lower-BMI group outside FDA obesity drug labels
Endpoints News 2025-12-15 Aviceda's geographic atrophy drug fails mid-stage study. Can it do better in Phase 3?
Endpoints News 2025-12-15 Sanofi returns to Dren Bio for another B cell depletion therapy at $100M upfront
Endpoints News 2025-12-15 Western genetic medicine makers turn to Chinese investigator-initiated trials
Endpoints News 2025-12-13 Eli Lilly’s triple-G obesity readout; The latest Endpoints 100 results; Public biotechs cash in; and more
Endpoints News 2025-12-12 340B sales grew 23% last year, and court battle over pilot program intensifies
Endpoints News 2025-12-12 Covid vaccine deaths review sent to top of FDA, but with far less certain conclusions, sources say